Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo will shell out $250 million to acquire drugmaker Lannett, shoring up the Indian drugmaker’s footprint in the U.S.

Hyderabad: Amid rising fears of US President Donald Trump imposing tariffs on Indian pharma imports, Aurobindo Pharma is ...

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Indian exporters who built their businesses on Americans' demand for affordable goods are redrawing their strategies and ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

The transaction is valued at an enterprise value of $250 million (₹21,850 crore) on a cash-free, debt-free basis, including ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Gokaldas Exports Ltd., one of India’s largest apparel exporters that earns about 70% of its revenue from the US, plans to ...

Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or ...